Michael Joseph Wozniak, OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Ridings Ave, Molaia, OR 97038 Phone: 503-829-5591 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Researchers at Mount Sinai School of Medicine have found in a Phase II trial that a gene therapy developed at Mount Sinai stabilized or improved cardiac function in people with severe heart failure. Patients receiving a high dose of the therapy, called SERCA2a, experienced substantial clinical benefit and significantly reduced cardiovascular hospitalizations, addressing a critical unmet need in this population.
The New York Times: Rep. Paul Ryan, "as you may have heard, is the Republican star of the moment. A 40-year-old from southeastern Wisconsin serving his sixth term in the House, Mr. Ryan has been getting a lot of attention for his 'Roadmap for America's Future,' an unusually austere proposal to vanquish the federal debt by, among other things, partly dismantling Social Security and Medicare as they currently exist."
CytoDyn, Inc. has filed a new IND for a study to reconfirm dose ranging and to "prove the principle" with a randomized, double-blind placebo controlled study of Cytolin, the Company's first-in-class drug for treating HIV/AIDS. This comes 13 years after the first IND was issued for the drug.
Researchers at University of California, San Diego School of Medicine report that higher levels of vitamin D - specifically serum 25-hydroxyvitamin D - are associated with a correspondingly reduced risk of cancer. The findings are published in the April 6, online issue of PLOS ONE.
› Verified 3 days ago